CD1C and infection: Quantitative analysis of HIV-1SF33-infected cells showed that hBD-2PTD and hBD-3PTD reduced the infection of CD4+ T lymphocytes, CD68+ macrophages, and CD1c+ DC by 20–70% compared with untreated tissues.